OTLK: Outlook Therapeutics, Inc. Stock

by  •  • Comments Off on OTLK: Outlook Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 45.14
Enterprise Value ($M) 70.19
Book Value ($M) -50.29
Book Value / Share -1.57
Price / Book -0.90
NCAV ($M) -51.63
NCAV / Share -1.61
Price / NCAV -0.87

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.16
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.26
Current Ratio 0.32

Balance Sheet (mrq) ($M)
Current Assets 15.67
Assets 17.01
Liabilities 67.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -71.70
Net Income -75.37
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -68.79
Cash from Investing 0.00
Cash from Financing 60.33

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Sphera Funds Management Ltd. 5.21
02-14 13G/A Tang Capital Partners Lp 6.40 -24.07
02-14 13G/A Great Point Partners Llc 8.18 -10.56
01-22 13D/A GMS Ventures & Investments 38.60 37.32
11-07 13G/A Velan Capital Investment Management LP 3.10 -40.00
04-17 13D/A Syntone Ventures LLC 11.40 -85.99

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2025-01-23 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2024 ☐TRANSITION REPOR
2024-12-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-11 92,179 241,007 38.25
2025-03-10 71,610 219,460 32.63
2025-03-07 68,219 209,874 32.50
2025-03-06 54,284 243,844 22.26

(click for more detail)

Similar Companies
ONVO – Organovo Holdings, Inc. ORGO – Organogenesis Holdings Inc.
ORMP – Oramed Pharmaceuticals Inc. PALI – Palisade Bio, Inc.
PASG – Passage Bio, Inc.


Financial data and stock pages provided by
Fintel.io